Clinical trial
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
NCT01134822 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
- Lead sponsor
- University of Nottingham
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2010
- Completion date
- September 5, 2017
- Enrollment
- 330 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.